Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
Karin Neukam(Hospital Universitario de Valme), Juan A. Pineda(Hospital Universitario de Valme), Antonio Rivero(University of Southern California), Ángela Camacho(Hospital Universitario Reina Sofía), Luís F. López‐Cortés(Instituto de Salud Carlos III), Jacob Nattermann(University Hospital Bonn), Jürgen K. Rockstroh(University of Bonn), Norma Rallón(Hospital Universitario Rey Juan Carlos), José M. Benito(Hospital Universitario Rey Juan Carlos), Almudena Torres-Cornejo(Instituto de Biomedicina de Sevilla), Jesús Gómez‐Mateos(Hospital Universitario de Valme), Antonio Carúz(Universidad de Jaén), Juan Macı́as(Hospital Universitario de Valme)
Cited by 43
Related Papers
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection
|AIDS|2003|355
The HLA-A2 Restricted T Cell Epitope HCV Core35–44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer Cells
|American Journal Of Pathology|2005|171